NavigationUser login |
First-Time Generic Coreg Approvals
The first generic versions of Coreg (carvedilol) were approved by the US Food and Drug Administration on September 5, 2007. Carvedilol, a beta-blocker medication, controls high blood pressure and treats heart failure. Several manufacturers will market carvedilol in four strengths. At this time the approved manufacturers are Actavis, Apotex, Aurobindo, Caraco, Dr. Reddy’s, Glenmark, Lupin, Mylan, Ranbaxy, Sandoz, Taro, Teva, Watson and Zydus. Pill imprints for all strengths of carvedilol are summarized below for those manufacturers who have commenced marketing the drug. We will update the table when more information becomes available. Carvedilol ApprovalsPill Identification by Manufacturer
( categories: New Medicines )
|
Joined: 2005-01-07